Biolegend, 317305, FITC anti-human CD3 Antibody, 25tests

CD3ε is a 20 kD chain of the CD3/T cell receptor (TCR) complex, which is composed of two CD3ε, one CD3γ, one CD3δ, one CD3ζ (CD247), and a T cell receptor (α/β or γ/δ) heterodimer. It is found on all mature T lymphocytes, NK T cells, and some thymocytes. CD3, also known as T3, is a member of the immunoglobulin superfamily that plays a role in antigen recognition, signal transduction, and T cell activation.
25tests
Verified Reactivity: Human
Antibody Type: Monoclonal
Host Species: Mouse
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation: The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration: Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.
Excitation Laser: Blue Laser (488 nm)
Application Notes: The OKT3 monoclonal antibody reacts with an epitope on the epsilon-subunit within the human CD3 complex.Clone OKT3 can block the binding of clones SK7 and UCHT1.4 The OKT3 antibody is able to induce T cell activation. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections and activation of T cells. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 317304). For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 317326) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York. Knapp W. 1989. Leucocyte Typing IV. Oxford University Press New York. Barclay N, et al. 1997. The Leucocyte Antigen Facts Book. Academic Press Inc. San Diego. Li B, et al. 2005. Immunology 116:487. Jeong HY, et al. 2008. J. Leuckocyte Biol. 83:755. PubMed Alter G, et al. 2008. J. Virol. 82:9668. PubMed Manevich-Mendelson E, et al. 2009. Blood 114:2344. PubMed Pinto JP, et al. 2010. Immunology. 130:217. PubMed Biggs MJ, et al. 2011. J. R. Soc. Interface. 8:1462. PubMed
Product Citations: Gkika E, et al. 2023. NPJ Precis Oncol. 7:24. PubMed Li D, et al. 2023. Int J Oncol. 62:. PubMed Li L, et al. 2023. Heliyon. 9:e14219. PubMed Deng G, et al. 2023. Cancers (Basel). 15:. PubMed Kim JH, et al. 2020. Sci Rep. 10:1835. PubMed Zhang T, et al. 2022. Am J Reprod Immunol. 87:e13524. PubMed Tessaro FHG, et al. 2022. Cell Rep. 39:110977. PubMed Deepak HB, et al. 2022. Indian J Pharmacol. 54:183. PubMed Rosato F, et al. 2022. J Transl Med. 20:578. PubMed Zhang W, et al. 2022. Front Cell Dev Biol. 10:842813. PubMed Guo X, et al. 2016. Mol Ther Methods Clin Dev. 3:15054. PubMed Zitti B, et al. 2017. Sci Rep. 10.1038/s41598-017-10403-0. PubMed Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed Want MY, et al. 2019. Oncoimmunology. 8:e1586042. PubMed Lugo-Reyes SO, et al. 2021. J Clin Immunol. 41:1291. PubMed Hess NJ, et al. 2020. J Immunol. 205:272. PubMed Clayton K, et al. 2014. J Immunol. 192:782. PubMed Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed Catapano M, et al. 2020. J Invest Dermatol. 140:816. PubMed Wang Y, et al. 2019. J Transl Med. 17:93. PubMed Wu X, et al. 2020. Cancers (Basel). 12:. PubMed Moen IN, et al. 2021. Cell Death Discov. 7:36. PubMed Dai Q, et al. 2020. Front Immunol. 11:539654. PubMed Yamada E, et al. 2021. Gut Microbes. 13:1997292. PubMed Zhang B, et al. 2022. J Exp Med. 219:. PubMed Lin L, et al. 2018. Oncol Lett. 16:1259. PubMed Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed Zhang Z, et al. 2021. Acta Pharm Sin B. 11:1965. PubMed Celik H, et al. 2021. Cancer Discov. 11:3126. PubMed Fujigaki J, et al. 2015. PLoS One. 10: 0132521. PubMed Giesecke C, et al. 2017. Cytometry A. 10.1002/cyto.a.23250. PubMed Gillissen MA, et al. 2018. Blood. 131:131. PubMed James KR, et al. 2020. Nat Immunol. 1.113194444. PubMed Kim K, et al. 2019. Nat Microbiol. 1.586111111. PubMed Sperk M, et al. 2021. iScience. 24:102111. PubMed Nakasone H, et al. 2021. Commun Biol. 4:1177. PubMed Wu X, et al. 2021. Front Immunol. 12:731767. PubMed Jeyanathan M, et al. 2022. JCI Insight. 7:. PubMed Omer OS, et al. 2020. Methods Mol Biol. 2121:199. PubMed Hazenberg MD, et al. 2019. Blood Adv. 2.659722222. PubMed Golebski K, et al. 2021. Immunity. 54(2):291-307.e7. PubMed Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed Agashe VV, et al. 2018. J Immunol. 201:772. PubMed Oyer JL, et al. 2022. Front Immunol. 13:861681. PubMed Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed Aagaard K, et al. 2017. Sci Rep. 7:41389. PubMed Miyamae Y, et al. 2020. Cell Chemical Biology. 27(12):1573-1581.e3. PubMed Cheng J, et al. 2022. iScience. 25:103588. PubMed Tsai HI, et al. 2021. EMBO Mol Med. 13:e12834. PubMed Zhang W, et al. 2022. J Transl Med. 20:558. PubMed Zhao B, et al. 2013. PLoS One. 8:77708. PubMed Bal S, et al. 2016. Nat Immunol. 10.1038/ni.3444. PubMed Winkler C, et al. 2021. JCI Insight. 6:. PubMed Akusjärvi SS, et al. 2022. iScience. 25:103607. PubMed Zhou Z, et al. 2022. J Gastrointest Oncol. 13:732. PubMed Loo Yau H, et al. 2021. STAR Protocols. 2(2):100549. PubMed Shikhagaie M, et al. 2017. Cell Rep. 18(7):1761-1773. PubMed Gopalakrishnapillai A, et al. 2021. Cancers (Basel). 13:. PubMed Fierle JK, et al. 2021. Cell Reports Medicine. 2(8):100362. PubMed Sullivan KD et al. 2016. eLife. 5 pii: e16220. PubMed Ochi T, et al. 2011. Blood. 118:1495. PubMed Svensson Akusjärvi S, et al. 2022. Commun Biol. 5:357. PubMed
RRID: AB_571906 (BioLegend Cat. No. 317305) AB_571907 (BioLegend Cat. No. 317306)
Structure: Ig superfamily, the subunits CD3γ, CD3δ, CD3ζ (CD247) and TCR (α/β or γ/δ) form the CD3/TCR complex, 20 kD
Distribution: Mature T and NK T cells, thymocyte differentiation
Function: Antigen recognition, signal transduction, T cell activation
Ligand/Receptor: Peptide antigen bound to MHC
Cell Type: NKT cells, T cells, Thymocytes, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules
Antigen References: Barclay N, et al. 1993. The Leucocyte FactsBook. Academic Press. San Diego. Beverly P, et al. 1981. Eur. J. Immunol. 11:329. Lanier L, et al. 1986. J. Immunol. 137:2501.
Gene ID: 916
UniProt: View information about CD3 on UniProt.org
Clone: OKT3
Regulatory Status: RUO
Workshop: HCDM listed
Other Names: T3, CD3ε
Isotype: Mouse IgG2a, κ